AC
EMN icon

Aristides Capital’s Eastman Chemical EMN Stock Holding History

Aristides Capital’s Portfolio EMN Stock Details EMN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-2,853
Closed -$251K – 243
2025
Q1 		$251K Sell
2,853
-468
-14% -$44.2K 0.07% 174
2024
Q4 		$303K Buy
+3,321
New +$341K 0.06% 169
2024
Q3 		– Sell
-2,599
Closed -$255K – 265
2024
Q2 		$255K Buy
+2,599
New +$258K 0.07% 181

Other funds holding EMN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Aristides Capital's EMN Position: Q2 2025 in Review

Aristides Capital sold out of Eastman Chemical (EMN) in Q2 2025, closing a stake of 2,853 shares — an estimated $251K sold.

Aristides Capital first reported a position in EMN in Q2 2024 and held it in 3 quarters. The position peaked at $303K in Q4 2024. 751 funds tracked by Wall St. Rank hold EMN as of Q2 2025.

  • Aristides Capital reported no remaining Eastman Chemical position as of Q2 2025 after selling out during the quarter.
  • Aristides Capital sold 2,853 Eastman Chemical shares in Q2 2025, an estimated $251K.
  • Aristides Capital first reported a position in Eastman Chemical in Q2 2024 and held it in 3 quarters.
  • Aristides Capital's Eastman Chemical position peaked at $303K in Q4 2024.
  • 751 funds tracked by Wall St. Rank held Eastman Chemical as of Q2 2025.

Based on Aristides Capital's 13F filing for Q2 2025, filed 13 Aug 2025.